Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit follow the Company on LinkedIn and X.

We are seeking a highly skilled and detail-oriented Corporate & Securities Counsel to join our growing legal team. This individual will play a critical role in supporting the company’s public company reporting obligations and broader corporate governance needs. The ideal candidate will bring strong securities law experience from a top law firm and/or in-house legal department, with the ability to independently manage SEC filings and contribute to a range of corporate legal matters.

Associate Director/Director, Corporate & Securities Counsel